Why Shares of Adagio Therapeutics Soared 25.9% on Thursday

Why Shares of Adagio Therapeutics Soared 25.9% on Thursday
·3 min read

The clinical-stage biotech company is working on an antiviral treatment to fight multiple variants of COVID-19.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting